mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.003 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.1 |